Cineverse Corp. CNVS Balance Sheet Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $3.39M+37.6% | $2.46M+5.4% | $2.34M+17.7% | $1.99M-85.8% | $13.94M+129% | ||
| $38.6M+122% | $17.4M+26.6% | $13.75M-14.5% | $16.07M+2.0% | $15.75M-53.6% | ||
| $50.78M+73.7% | $29.23M+25.7% | $23.26M-6.5% | $24.86M-34.7% | $38.08M-24.6% | ||
| $3.91M+10.7% | $3.53M+14.9% | $3.07M+3.4% | $2.97M+3.2% | $2.88M-1.7% | ||
| $21.22M+212% | $6.8M0.0% | $6.8M0.0% | $6.8M0.0% | $6.8M0.0% | ||
| $370K-97.9% | $17.73M-3.7% | $18.41M-0.2% | $18.45M+378% | $3.86M-78.4% | ||
| $130.28M+90.0% | $68.57M+10.7% | $61.95M+0.7% | $61.53M-15.1% | $72.52M-10.0% | ||
| $63.01M+106% | $30.65M+25.0% | $24.52M-2.4% | $25.14M-27.0% | $34.44M-21.3% | ||
| $23.45M-23.9% | $30.83M+24.4% | $24.78M-2.3% | $25.38M-26.9% | $34.72M-21.2% | ||
| $199K+1.0% | $197K0.0% | $197K+1.0% | $195K+0.5% | $194K0.0% | ||
| -$510.1M+0.2% | -$511.25M-0.2% | -$510.24M-1.1% | -$504.56M-0.7% | -$500.91M+0.2% | ||
| $44.32M+14.9% | $38.57M+1.4% | $38.04M+2.6% | $37.07M-4.3% | $38.75M+3.5% | ||
| $130.28M+90.0% | $68.57M+10.7% | $61.95M+0.7% | $61.53M-15.1% | $72.52M-10.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cineverse Corp.'s total assets?
- Cineverse Corp. (CNVS) holds $130.3M in total assets, up 79.7% year over year.
- How much debt does Cineverse Corp. have?
- Cineverse Corp. carries $403.0K in total debt against $44.3M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Cineverse Corp. have?
- Cineverse Corp. holds $3.4M in cash and equivalents.
- Can Cineverse Corp. cover its short-term obligations?
- Its current ratio is 0.81 — current liabilities exceed current assets.
- Where does Cineverse Corp.'s balance sheet data come from?
- Every line is extracted from Cineverse Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
